Phenprocoumon
From Wikipedia, the free encyclopedia
| Image:Phenprocoumon.svg | |
| Phenprocoumon
| |
| Systematic (IUPAC) name | |
| 2-hydroxy-3-(1-phenylpropyl)chromen-4-one | |
| Identifiers | |
| CAS number | 435-97-2 |
| ATC code | B01AA04 |
| PubChem | 9908 |
| DrugBank | APRD00228 |
| Chemical data | |
| Formula | C18H16O3 |
| Mol. weight | 280.318 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 99% |
| Metabolism | hepatic to inactive metabolites |
| Half life | 5 to 6 days |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Phenprocoumon is a anticoagulant, functioning as a Vitamin K antagonist. It is a derivative of coumarin and is also marketed under the brand name Marcoumar. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders.
[edit] External links

